During the past decade, Uzsoki Utcai Korhaz conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 32 clinical trials were completed, i.e. on average, 62.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 16 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uzsoki Utcai Korhaz" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Pfizer" with 6 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uzsoki Utcai Korhaz" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Parexel" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Uzsoki Utcai Korhaz" are "Breast Cancer" (8 trials), "Multiple Sclerosis" (7 trials), "Prostate Cancer" (4 trials), "Heart Failure" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Uzsoki Utcai Korhaz" in a lesser frequency.

Most popular intervention types in "Uzsoki Utcai Korhaz" are "Drug" (73 trials), "Device" (7 trials), "Other" (7 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Docetaxel" (7 trials), "Carboplatin" (6 trials), "Capecitabine" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Uzsoki Utcai Korhaz" are 71 trials for "All" genders, 9 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Uzsoki Utcai Korhaz". undefined are not yet recruiting, 8 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Uzsoki Utcai Korhaz, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Uzsoki Utcai Korhaz, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

Uzsoki Utcai Korhaz has several departments that took part in Clinical trials: "Uzsoki Utcai Korhaz; Onkoradiológiai Osztály" - 9 trials